INTRODUCTION
Interleukin-10 (IL-10) is a potent regulator of inflammatory responses 1 and plays a critical role in controlling allergic airway inflammation. 2 Compared with nonasthmatics, asthmatic individuals have been reported to have reduced levels of IL-10 in bronchoalveolar lavage fluid, 3 with decreased secretion of IL-10 from alveolar macrophages. 4 Furthermore, polymorphisms in the IL10 gene resulting in low IL-10 production have been associated with severe asthma, 5 suggesting that IL-10 is a major determinant in the development and severity of airway allergy. In murine models, Il10 -/-mice develop enhanced allergic responses to a variety of allergens [6] [7] [8] and develop increased eosinophilic airway inflammation. These studies highlight a clear non-redundant role for IL-10 in controlling allergen-induced airway disease. To date, the only preventative treatment for allergic asthmatics is allergen-specific immunotherapy. 9 Although the precise mechanisms are unclear, successful allergen-specific immunotherapy correlates with the development of IL-10-secreting antigen-specific T cells, 10 suggesting that the balance between IL10-secreting cells and pathogenic cells is an important determinant in the development of allergic disease. 11 Despite the central role of IL-10 in controlling allergic responses, the target of IL-10 signaling in this setting has not been clearly described. Classically, the effects of IL-10 on T-cell responses were thought to occur indirectly through antigenpresenting cells (APCs). 12, 13 Recent reports, however, indicate that IL-10 can signal directly on subsets of T cells, including memory/effector T cells in a model of colitis, 14 T helper type 17 (Th17) cells during intestinal inflammation, 15 and regulatory T (Treg) cells for the prevention of Th17-mediated colitis. 16 In addition, in vitro data suggested that IL-10 can directly regulate IL-5 and IL-4 in cultured T cells. 17, 18 Therefore, we hypothesized that IL-10 signaling directly in T helper type 2 (Th2) cells could contribute to regulation of Th2-mediated allergic airway responses. Here, we investigated the role of IL-10 signaling in Th2 cells in a mouse model of house dust mite (HDM)-induced allergic airway inflammation and showed that IL-10 signaling in Th2 cells regulated the severity of allergic airway responses. RNA sequencing (RNA-Seq) identified that IL-10 regulated several genes in Th2 cells including Granzyme b. We found that IL-10 regulated granzyme B in Il10 -/-cells that correlated with increased Th2 cell death. Finally, adoptive transfer of Il10r-deficient Il4 gfp þ Th2 cells alone was sufficient to orchestrate severe allergic airway inflammation in wild-type (WT) mice, identifying that IL-10-mediated regulation of Th2 cells in vivo is an important and previously overlooked axis of immune regulation, preventing the development of severe airway inflammation.
RESULTS

IL-10R signaling in T cells regulates Th2 cell differentiation and HDM-induced airway allergy
To investigate whether IL-10 signaling in T cells was important during airway allergy, we conditionally deleted the IL-10 receptor-a (IL-10RA) subunit in T cells by crossing Il10ra fl/fl mice with Cd4
Cre mice. 19 Mice were sensitized to HDM via the intraperitoneal route and were challenged by intratracheal delivery of HDM to establish a localized T cell-driven airway inflammatory response ( Figure 1a) . HDM-challenged mice with Il10ra-deficient T cells had significantly increased cellular infiltration and eosinophilia in the alveolar spaces, compared with Il10ra-sufficient mice (Figure 1b CD4 is expressed on a subset of dendritic cells and transiently expressed on CD8 þ cells during T-cell development. It was therefore possible that the in vivo observations described above were a consequence of IL-10R deletion on CD4 þ dendritic cells or CD8 þ T cells. To determine whether IL-10 could directly regulate cytokine production in CD4 þ T cells, we used fluorescence-activated cell sorting (hereafter referred to as 'sorting') to purify naive TCRb þ CD4 þ T cells and polarized these under Th2 conditions in the absence of APCs. We observed a higher frequency of IL-4 þ and IL-13 þ cells from as early as day 7 in Cd4 Cre Il10ra fl/fl Th2 cultures compared with Cd4
Cre Il10ra þ / þ cultures, with a further increase in IL-4 þ , IL-13 þ , and IL-5 þ cells after 14 days (Figure 2g ), indicating that IL-10 can directly regulate Th2 cell differentiation.
IL-10 induces tyrosine phosphorylation of signal transducer and activator of transcription 3 (STAT3) in monocytes and lymphocytes. 21 To determine whether STAT3 expression and phosphorylation was regulated by IL-10 in Th2 cells, we measured STAT3 in Il10ra-sufficient and Il10ra-deficient naive T cells and in Th2 committed cells following 3 days of Th2 polarization. Il10ra-sufficient and -deficient naive T cells had similar levels of total STAT3 and, as expected, very little phosphorylated STAT3 (pSTAT3). Of note, there was a reduction in total pSTAT3 in Cd4
Cre Il10ra fl/fl Th2 cells compared with Cd4
Cre Il10ra þ / þ Th2 cells (Figure 2h and Supplementary Figure S2A) , indicating that IL-10R-signaling was required for optimal STAT3 levels and phosphorylation of STAT3. WT T cells cultured under Th2 conditions in the presence of an IL-10R blocking antibody (anti-IL-10R) also had reduced pSTAT3 as compared with WT cells treated with an isotype control antibody (Supplementary Figure S2B) . Il10ra-deficient T cells also secreted less IL-10 under Th2 conditions in vitro (Supplementary Figure S2C) with proportionally fewer IL-10 þ cells in the lungs of mice with HDM-induced airway allergy (Supplementary Figure S1G ,H), suggesting that IL-10R signaling was required for optimal IL-10 production from Th2 cells. These data are in line with a previous report demonstrating that IL-10R-signaling was required for IL-10 production by Treg cells. 16 STAT6 was largely unaffected in Il10ra-deficient T cells (Figure 2h ).
Tissue-associated Th2 cells preferentially express Il10 and Il10ra
To determine the spatial expression of the IL-10R on Th2 cells in vivo, we sensitized and challenged Il4 gfp reporter mice 22 with HDM and sorted Th2 committed Il4 gfp þ cells from the lung tissue, local mediastinal lymph nodes, and spleen following HDM challenge. Th2 cells from the lung tissue had the highest relative expression of both Il10 and Il10ra as compared with Th2 cells from the spleen or mediastinal lymph nodes (Figure 3a,b) . Th2 cells in the lung also had a slightly higher expression of Il10ra compared with other T cells in the lung (Supplementary Figure S3A) . To determine whether Il10 and Il10r were coregulated in lung-derived Th2 cells, we crossed Il4 gfp -reporter mice with Il10-reporter mice (10BiT). 23 These dual reporter mice allowed us to sort-purify Il10-expressing Th2 cells (Il10
BiT þ Il4 gfp þ ) and nonexpressing Th2 cells (Il10
BiT-Il4 gfp þ ) from the allergic lung ( Figure 3c ). As expected, Il10
BiT þ Th2 cells had elevated expression of Il10 mRNA ( Figure 3d) ; however, both Il10
BiT þ and Il10 BiT-Th2 cells had comparable Il10ra expression (Figure 3e mice were harvested for cell lysates or polarized under Th2 conditions for 3 days. Total cultures were then harvested for lysates and western blot analysis for phosphorylated signal transducer and activator of transcription 3 (pSTAT3), total STAT3, pSTAT6, total STAT6, and Actin as a loading control. Data are representative of two separate experiments with densitometry used to determine the ratio of phosphorylated/total protein level. Mann-Whitney tests were used to determine significance with Pp0.05 considered significant, marked with an asterisk (*). AU, arbitrary unit.
crossed Cd4 Cre Il10ra fl/fl or Cd4 Cre Il10ra þ / þ mice with Il4 gfp reporter mice, 22 allowing us to sort-purify Il10ra-sufficient and Il10ra-deficient Il4 gfp þ Th2 cells from the lung tissue of allergic mice (Figure 4a,b) . RNA was extracted from enriched and sortpurified lung-derived Il4 gfp þ Th2 cells and used for transcriptional analysis using RNA-Seq. The transcriptome of Il10ra-sufficient and Il10ra-deficient Il4 gfp þ Th2 cells were surprisingly similar with only 36 genes significantly different (Po0.05, 42-fold change, Figure 4c ). Applying a fivefold change filter between Il10ra-sufficient and Il10ra-deficient Il4 gfp þ Th2 cells and a minimum read count of 20, we identified 6 genes that were significantly different between Il10ra-sufficient and Il10ra-deficient Il4 gfp þ Th2 cells (Figure 4d ).
These genes included Il10ra and Gzmb (granzyme B), which were downregulated in Il10ra-deficient Il4 gfp þ Th2 cells, and Bc049352, Tmprss13, Scn4b, and Fxyd6, which were upregulated in Il10ra-deficient Il4 gfp þ Th2 cells ( Figure 4e ). Following the report that granzyme B expression in Th2 cells was required for T-cell receptor (TCR)-induced Th2 cell death, 24 we hypothesized that IL-10R signaling was required for granzyme B-mediated Th2 cell death, providing an explanation for exacerbated Th2-mediated inflammation in mice with Il10ra-deficient T cells. Granzyme B protein was also reduced in Il10ra-deficient Th2 cells generated in vitro as compared with Il10ra-sufficient Th2 cells (Figure 5a To test whether Il10ra-deficient Th2 cells were indeed responsible for the increased airway inflammation in vivo and whether IL-10 acted directly on Th2 cells, we developed an adoptive transfer system, transferring activated congenic
Cre Il10ra fl/fl Il4 gfp þ ) mice to WT mice. Recipient mice were given localized HDM challenges to reactivate transferred Th2 cells (Figure 6a ). This system removed the influence of Il10ra-deficient CD4 þ dendritic cells, Il10ra-deficient CD8
þ cells, and Il10ra-deficient Treg cells 16 in vivo. HDM-mediated reactivation of transferred Il10ra-deficient Th2 cells led to an increased influx of cells into the alveolar 
BiT À cells were sorted from lungs (c), harvested for RNA, and analyzed by RT-PCR for expression of Il10 and Il10ra, relative to Hprt. Data are representative of two independent experiments; sorted cells were pooled from five mice per group. space (bronchoalveolar lavage), with significantly more eosinophils and macrophages compared with mice that received Il10ra-sufficient Th2 cells (Figure 6b,c) . Il10ra-deficient Th2 cells also supported the differentiation and recruitment of host (CD45.2 þ ) T cells into Th2 cells with increased host IL-5 þ and IL-13 þ Th2 cells in the lungs of recipient mice (Figure 6d-f) . Finally, to determine whether Il10ra-deficient Th2 cells survived better than Il10ra-sufficient cells in vivo, we used a similar adoptive transfer system as above (Figure 6a ), but cotransferred congenically marked Cd45.1 þ /-Il10ra-deficient Il4 gfp þ Th2 cells and Cd45.1 þ Il10ra-sufficient Il4 gfp þ Th2 cells in equal numbers into recipient Cd45.2 þ mice, normalizing any differences in the local inflammatory milieu (Figure 6a , Group 3). Using this system, we observed that Il10ra-deficient Th2 cells survived significantly better in the lung and local lymph node as compared with Il10ra-sufficient Th2 cells (Figure 6g,h) . Furthermore, Il10ra-deficient Th2 cells further upregulated Il4 gfp , with greater fluorescence intensity, than Il10ra-sufficient Th2 cells (Figure 6h,i) and had less granzyme B expression in the lung, but not the local lymph node 
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MucosalImmunology | VOLUME 10 NUMBER 1 | JANUARY 2017 (Figure 6h,j) , supporting the notion that local IL-10R signaling significantly regulates Th2 cell survival, in part via granzyme B. Taken together, these data demonstrate that IL-10R signaling in Th2 cells is required to control Th2 cell survival in vivo and functions as an important regulatory axis limiting Th2-mediated allergic responses in the lung.
DISCUSSION
In summary, our data have identified that IL-10 plays a critical role in directly regulating Th2 cells during HDM-induced airway inflammation. We report that mice with T cells deficient in Il10ra have increased allergic airway and lung inflammation and that IL-10 directly regulates Th2 cell differentiation and survival. The specific loss of IL-10R signaling in HDM-elicited Th2 cells resulted in a variety of transcriptional changes, including the significant reduction of granzyme B. In vitro, we demonstrate that IL-10-induced granzyme B in Th2 cells contributes significantly to TCR-induced Th2 cell death, providing a mechanistic explanation of how IL-10R signaling directly regulates Th2-mediated responses.
The heightened allergic response we observed in Cd4 Cre Il10-ra fl/fl mice was broadly in line with previous studies that define the importance of IL-10 as a regulatory cytokine in allergic inflammation. 2 However, our data identify that IL-10 also functions as a direct regulator of T-cell differentiation and that IL-10 signaling in T cells is critical to prevent severe allergic responses (Figures 1 and 2) . Furthermore, we demonstrate that IL-10 is important in regulating Th2 cell differentiation in vivo, and that IL-10RA signaling in differentiated Th2 cells alone is required to prevent allergic responses ( Figure 5) . Although IL-10 regulation of T-cell responses has classically been attributed to indirect action via APCs, 12,13 our data add IL-10 regulation of Th2 cells to the growing body of literature showing that IL-10 can act directly on T cells. 
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+/+ rIL-10 shown (g, h) . The geometric mean fluorescence intensity (gMFI) for Il4 gfp (h, i) and granzyme B (h, j) is shown. Data are representative of two separate experiments with Mann-Whitney tests used to determine significance with Pp0.05 considered significant, marked with an asterisk (*); n ¼ 3-5 mice per group.
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In addition to heightened allergic responses in Cd4
Cre Il10ra fl/fl mice, we observed enhanced Th2 cytokine-expressing cells in the lungs and lymph nodes (Figure 2) . In vitro, Th2 cells polarized more readily toward the Th2 fate ( Figure 2) . This is in accordance with previous data showing that IL-5 and IL-4 can be directly regulated by IL-10 in T-cell cultures. 17, 18 However, when we purified Il4 gfp þ Th2 cells from allergic Cd4
Cre Il10ra fl/fl or Cd4
Cre Il10ra þ / þ mice, we find similar expression of Il4, Il5, and Il13 when RNA was normalized, suggesting that this regulation occurs on a population level. In this HDM-induced allergy model, Th1 and Th17 responses were unchanged or reduced in Cd4   Cre   Il10ra fl/fl mice (Figure 2e,f) , suggesting that IL-10-mediated regulation of these responses is either context specific 15 or occurs via APCs during airway allergy. Both STAT3 and pSTAT3 were reduced in Cd4
Cre Il10ra
fl/fl
Th2 cells (Figure 2h ), indicating that IL-10 contributes to STAT3 phosphorylation and total STAT3 levels, possibly via auto regulation of STAT3. 25 In addition, Il10ra fl/fl Th2 cells secreted less IL-10 in vitro that may contribute to reduced pSTAT3 levels in Th2 cells and explain the enhanced inflammatory response in vivo. Residual pSTAT3 in Il10ra-deficient Th2 cells was sufficient for Th2 differentiation, unlike complete Stat3 -/-T cells that fail to differentiate into Th2 cells. 26 Taken together, these data demonstrate that IL-10R signaling in T cells regulates the magnitude and severity of airway allergy. In particular, IL-10R signaling via STAT3 regulates Th2 cell differentiation in vitro and in vivo following HDM exposure.
The kinetics and regulation of Il10 and Il10ra expression in T cells has been the focus of many studies. We observed that both Il10 and Il10ra were coexpressed greatest in tissue-derived Th2 cells as compared with lymph node-derived Th2 cells (Figure 3) . IL-4, GATA-3, and STAT6 are required for IL-10 production from Th2 cells, [27] [28] [29] but the precise signaling events that induce Il10 expression in Th2 cells in vivo are unclear. Our data suggest that either local inflammatory or tissue-derived signals stimulate Il10 expression in Th2 cells. For example, tissue-derived Th2 cells respond in an antigen receptorindependent, innate-like manner, producing IL-13 in response to IL-33. 30 Whether local IL-33 also regulates IL-10 expression in Th2 cells is currently unclear. IL-10 signaling in Th2 cells was required for IL-10 production, as tissue-derived or in vitro generated Il10ra-deficient Th2 cells had lower Il10 expression than Il10ra-sufficient Th2 cells. Whether an IL-10 autocrine regulatory loop supports IL-10 secretion in Th2 cells or whether B cell-and T cell-derived IL-10, which also potently suppresses innate and adaptive immune responses associated with airway allergy, 31, 32 regulates Th2 cell-derived IL-10 is currently unclear. An autocrine IL-10 loop is supported by the coexpression of Il10 and Il10ra in tissue-derived Th2 cells, and is in line with observations in Treg cells. 16 IL-10R signaling also regulated granzyme B expression in Th2 cells. Although it was previously unclear how granzyme B was regulated in Th2 cells, it has been shown that IL-10 can induce granzyme B expression in CD8 þ T cells, 33 and we now show here that IL-10 can regulate granzyme B in CD4 þ T cells.
Similarly, it has been known for several years that CD4 þ Th2 cells, 34, 35 CD4 þ cytotoxic Th1-like cells, 36 and CD4 þ Treg cells 37 express granzyme B with functional studies, using granzyme B-deficient mice or granzyme B inhibitors, clearly demonstrating that granzyme B is required for TCR-induced Th2 cell death. 24, 35 Taken together with these previous observations, we now provide evidence that IL-10R signaling in Th2 cells provides an upstream mechanism, upregulating granzyme B in Th2 cells for TCR-induced Th2 cell death. This pathway provides an explanation for the elevated Th2 cellmediated airway inflammation observed in mice with, or given, Il10ra-deficient Th2 cells. In particular, Th2 cells in the lung, which had the highest expression of Il10ra and produced the highest amount of Il10, appeared to be more tightly regulated by IL-10 than Th2 cells in the local lymph node (Figure 6 ). These observations lead to the hypothesis that IL-10 may function to directly regulate T cells in the tissue as compared with IL-10 acting on APCs in the lymph node; however, this hypothesis requires testing.
Overall, these data provide new insight into IL-10-mediated regulation of allergic airway inflammation and identify that pathogenic Th2 cells are an important direct target of IL-10. Thus, therapeutic use of IL-10 20,38 to treat airway inflammatory conditions may directly impact antigen-reactive pathogenic T cells, expanding the broad immunosuppressive properties of IL-10. 
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In vivo experiments were performed using female mice; all mice were on the C57Bl/6 background. All animal experiments were carried out following UK Home Office regulations (project license 80/2506) and were approved by The Francis Crick Institute Ethical Review Panel.
Cell sorting and flow cytometry. Cell sorting was performed using a FACS Aria II (BD Biosciences, San Jose, CA), MoFlo XDP (Beckman Coulter, Brea, CA), or Influx (BD Biosciences) cell sorter. For lungs, tissue was first digested for 45 min at 37 1C in 1 mg ml À 1 Liberase (Roche, Basel, Switzerland) with 0.024 mg ml À 1 DNase I (Roche) in Iscove's modified Dulbecco's medium (Gibco, Thermo Fisher, Waltham, MA) and filtered through a 40 mM cell strainer. To prepare cells for sorting, CD4
þ cells were first positively selected using MACS CD4 beads and magnetic columns (Miltenyi Biotec, Bergisch Gladbach, Germany) and were then stained for 25 min with antibodies in phosphate-buffered saline (PBS) with 1% fetal calf serum FCS. To prepare for sorting, stained cells were diluted in phenol-red free Iscove's modified Dulbecco's medium (Gibco) (with 1% fetal calf serum, 2 mM EDTA (Invitrogen, Carlsbad, CA), 100 U ml À 1 penicillin, and 100 mg ml À 1 streptomycin (Gibco), 8 mM L-glutamine (Gibco), and 0.05 mM 2-mercaptoethanol (Gibco)). PI was used to determine cell viability. Intracellular cytokine staining was performed following 6 h of restimulation with 50 ng ml In analysis experiments, viability was determined using the Molecular Probes Live/Dead Fixable Blue Dead Cell Stain Kit (Life Technologies, Carlsbad, CA).
HDM-induced airway allergy. Mice were sensitized intraperitoneally. with 10 mg HDM (Greer, Lenoir, NC) or PBS and 2 mg Imject Alum (Thermo Scientific) and challenged intratracheally with 10 mg HDM or PBS. Bronchoalveolar lavage using 1.5 ml PBS was performed to recover cells for Cytospin and differential counts, following staining with Accustain Wright-Giemsa stain, modified (Sigma). Then, 2-3 lung lobes were harvested for flow staining experiments. For histology, lungs were fixed in 4% formaldehyde (VWR, Radnor, PA) followed by 70% ethanol and then prepared for staining with Alcian blue/periodic acid-Schiff and hematoxylin and eosin. Slides were scored on a 0-4 scale for mucus and inflammation, as previously described, 6 with modifications. Briefly, for mucus score: the entire lung section was graded for presence of Goblet cells, 1; having more than 3 affected bronchioles, 2; having the entire ring stained in more than 3 bronchioles, 3; and presence of mucus plugs, 4. This score was averaged with an average score for five individual airways graded as: presence of Goblet cells, 1; 50% of bronchiole stained, 2; 100% of bronchiole stained, 3; and mucus plug, 4. Similarly, inflammation was graded as an average of the entire lung section score with the average scores of five individual airways. For entire lung section: presence of perivascular inflammation, 1; inflammation around 3 or more bronchioles, 2; dense inflammatory foci 3 cells deep, 3; and loss of lung architecture, 4. For each individual airway: presence of inflammation, 1; 50% inflammation around bronchiole, 2; 100% inflammation around bronchiole, 3; and dense inflammation bridging two bronchioles, 4. Half scores were given if between grades. Enzyme-linked immunosorbent assay. Total IgE enzyme-linked immunosorbent assay was performed by coating with Purified Rat AntiMouse IgE (R35-72, BD Pharmingen) at 2 mg ml À 1 overnight, followed by overnight incubation with serum and standard (Purified Mouse IgE, k isotype Standard, BD Pharmingen), and detection with Biotin Rat Anti-Mouse IgE at 1 mg ml À 1 (R35-118, BD Pharmingen), streptavidin horseradish peroxidase at 1:1,000 (BD Pharmingen), and ABTS One Component horseradish peroxidase Microwell Substrate (SurModics, Eden Prairie, MN). IL-10 was measured in culture supernatant using paired capture and detection antibodies (BD Pharmingen).
In vitro T-cell polarization and Th2 cell survival assay. Naïve CD4 þ T cells were sorted from spleens as CD4
gfp-PI -and cultured in vitro for 3 days with 10 ng ml À 1 IL-4 (R&D, Minneapolis, MN), 5 ng ml À 1 IL-2 (R&D), and 10 mg ml
anti-IFNg (XMG1.2, BioXcell, Minneapolis, MN) on flat-bottom 96-well plates coated with 1 mg ml À 1 anti-CD3 (17A2, BioXcell) and 10 mg ml À 1 anti-CD28 (37.51, BioXcell). On day 3, cells were split into round-bottom plates and supplemented with media containing 5 ng ml À 1 IL-2 (R&D). On day 7, cells were counted, washed, and repolarized for another week following the same timings as week 1. Th2 cell survival assays were performed as previously described. 24 Briefly, we generated Th2 cells for 7 days, as above. On day 7, Il4gfp þ PI -Th2 cells, or simply PI -cells when using Il10 -/-cells, were sort purified and stimulated on flat-bottom 96-well plates coated with 10 mg ml À 1 of anti-CD3 (17A2, BioXcell) for 24 h. Cultures were supplemented with recombinant IL-10(10 ng ml À 1 ) or a granzyme B inhibitor (10 mM, z-AAD-CH2Cl, Cambridge BioScience, Cambridge, UK) where indicated. PI incorporation, granzyme B expression, and total cell counts were performed after 24 h of culture.
Western blotting. Sorted naive or day 3 polarized Th2 cells were lysed in 1 Â RIPA buffer (500 mM Tris HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 0.5% deoxycholate, and 1% Nonidet-P40) containing protein inhibitors as per the manufacturer's instructions (Roche), 50 mM NaF, 1 mM Sodium ortho-vanadate, 100 nM Okadaic acid, and 2 mM sodium pyrophosphate tertrabasic. Protein concentration was determined using the Pierce BCA Protein Assay Kit (Life Technologies), lysates were resolved on a 10% Criterion TGX (Bio-Rad, Hercules, CA) or NuPage 4-12% Bis-Tris Gel (Life Technologies), and separated proteins were transferred onto Trans-Blot Turbo PVDF transfer (Bio-Rad) membranes. Membranes were blocked with 0.1% PBST (PBS with Tween 20) containing 5% milk (Sigma) and incubated with primary antibodies from Cell Signalling Technology (Danvers, MA): pSTAT3 (9145), pSTAT6 (9361), STAT3 (12640), and STAT6 (9362), followed by secondary (Rabbit IgG; GE Healthcare, Little Chalfont, UK) antibody in 0.1% PBST (Sigma) containing 5% milk (Sigma). Actin antibody was obtained from Santa Cruz Biotechnologies (C-11; Dallas, TX); secondary antibody for Actin was Rabbit Anti-Goat IgG (H þ L) horseradish peroxidase (Southern Biotech, Birmingham, AL). Membranes were washed in 0.1% PBST and specific bound antibodies were visualized by chemiluminescence (Amersham ECL (GE Healthcare), Immobilon; (Merck Millipore, Billerica, MA)).
Quantitative real-time reverse transcription-PCR. RNA was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germany). Complementary DNA was reverse transcribed from RNA using QuantiTect Reverse Transcription Kit (Qiagen) according to the manufacturer's instructions. Quantitative real-time reverse transcription-PCR analysis was performed using Power SYBR Green PCR master mix (Applied Biosystems, Foster City, CA) on an ABI Prism 7900HT Sequence Detection System (Applied Biosystems). Relative quantities of mRNA were determined by the comparative threshold RNA-Seq. RNA was isolated from cells using RNeasy Mini Kit according to the manufacturer's instructions (Qiagen). RNA-Seq libraries were constructed using the TruSeq RNA Sample Preparation Kit V2 according to the manufacturer's instructions (Illumina, San Diego, CA). Libraries were sequenced using the HiSeq 2500 System (Illumina).The raw Illumina reads were analyzed as follows. First, the data quality was analyzed using FastQC (www.bioinformatics. babraham.ac.uk/projects/fastqc). Low-quality bases were trimmed using Trimmomatic, 41 and the read pairs that passed the trimming quality filters were aligned to mm10 (Ensembl version 75) using Tophat2. 42 Counts were determined using htseq_count. 43 Normalization and statistical analysis was performed using edgeR. 44 Normalization and statistical analysis was performed using edgeR 44 with statistically significant genes (Po0.05) determined using a modified t-test with Benjamini-Hochberg multiple testing correction and a false discovery rate of o0.01.
Statistical analysis. Data sets were compared by Mann-Whitney test using GraphPad Prism (V.5.0, San Diego, CA). Differences were considered significant at *Pp0.05.
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